Esteban Jódar

Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial

W. Timothy Garvey, Rachel L. Batterham, Meena Bhatta et al. · Nature Medicine · 2022 · 787 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial

Bernhard Ludvik, Francesco Giorgino, Esteban Jódar et al. · The Lancet · 2021 · 610 citations

Medicine, Pharmacology, Pharmacotherapy +16

Oral Semaglutide Versus Empagliflozin in Patients With Type 2 Diabetes Uncontrolled on Metformin: The PIONEER 2 Trial

Helena W. Rodbard, Julio Rosenstock, Luís Henrique Santos Canani et al. · Diabetes Care · 2019 · 446 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Efficacy and Safety of IDegLira Versus Basal-Bolus Insulin Therapy in Patients With Type 2 Diabetes Uncontrolled on Metformin and Basal Insulin: The DUAL VII Randomized Clinical Trial

Liana K. Billings, Ankur Doshi, D. Gouet et al. · Diabetes Care · 2018 · 188 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +17

Bone mineral density measured by dual X-ray absorptiometry in Spanish patients with insulin-dependent diabetes mellitus

Manuel Muñoz‐Torres, Esteban Jódar, F. Escobar‐Jiménez et al. · Calcified Tissue International · 1996 · 172 citations

Medicine, Endocrinology, Radiology +17